Differentially expressed genes from pseudo-bulk analysis and the KEGG pathways of myeloid, lymphoid and fibroblast subsets. by Abishek Balakumar (20189865)

Presentation_1_Tristetraprolin limits age-related expansion of myeloid-derived suppressor cells.pptx by Kyu Hwan Kwack (5588222)

“…As TTP expression is known to decrease with age in myeloid cells, we used TTP-deficient (TTPKO) mice to model aged mice to study TTP regulation in age-related myelopoiesis. …”

Table_2_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…</p>Conclusion<p>Circulating non-myeloid cells display a unique transcriptomic pattern late after sepsis. …”

Table_3_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…</p>Conclusion<p>Circulating non-myeloid cells display a unique transcriptomic pattern late after sepsis. …”

Table_1_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…</p>Conclusion<p>Circulating non-myeloid cells display a unique transcriptomic pattern late after sepsis. …”

Table_7_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…</p>Conclusion<p>Circulating non-myeloid cells display a unique transcriptomic pattern late after sepsis. …”

Table_6_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…</p>Conclusion<p>Circulating non-myeloid cells display a unique transcriptomic pattern late after sepsis. …”

Table_5_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…</p>Conclusion<p>Circulating non-myeloid cells display a unique transcriptomic pattern late after sepsis. …”

Table_4_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…</p>Conclusion<p>Circulating non-myeloid cells display a unique transcriptomic pattern late after sepsis. …”

Image_1_Myeloid cell-derived catecholamines influence bone turnover and regeneration in mice.jpeg by Melanie R. Kuhn (13798336)

“…This indicates a crucial role of myeloid cell-derived catecholamines in immune cell-bone cell crosstalk and during fracture healing.…”

Image_2_Myeloid cell-derived catecholamines influence bone turnover and regeneration in mice.jpeg by Melanie R. Kuhn (13798336)

“…This indicates a crucial role of myeloid cell-derived catecholamines in immune cell-bone cell crosstalk and during fracture healing.…”

EF-24 treatment induces distinct gene expression changes in Kasumi-1 cells. by Ajeet P. Singh (22298432)

Subjects:

DataSheet_1_Autolysosomal activation combined with lysosomal destabilization efficiently targets myeloid leukemia cells for cell death.doc by Harshit Shah (9375656)

“…</p>Methods<p>We used a panel of multiple myeloid leukemia (ML) cell lines as well as leukemic patient samples and updated methodology to study auto-lysosomal compartment, lysosomal membrane permeabilization and lysosomal cell death.…”

Ribosomal protein subunit large (Rpl) and small (Rps) transcripts are expressed at decreased levels at the site of <i>L</i>. <i>major</i> infection. by Gopinath Venugopal (638444)

Flow cytometry gating strategy for analyzing IgM⁺, myeloid, and CD8⁺ subsets of kidney from brown trout. by Helena Saura Martinez (22305113)

EF-24 treatment disrupts key molecular pathways associated with cell survival, proliferation, and viability. by Ajeet P. Singh (22298432)

Subjects:

Image 5_COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity.pdf by Na He (295300)

“…Our results showed that effector CD8+ T (Teff) cells were significantly downregulated while naïve CD8+ T cells or Treg cells were obviously upregulated in P210-elevated CML patients after contracting COVID-19 compared to that in P210-unchanged or decreased CML patients. …”

Image 4_COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity.pdf by Na He (295300)

“…Our results showed that effector CD8+ T (Teff) cells were significantly downregulated while naïve CD8+ T cells or Treg cells were obviously upregulated in P210-elevated CML patients after contracting COVID-19 compared to that in P210-unchanged or decreased CML patients. …”

Image 3_COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity.pdf by Na He (295300)

“…Our results showed that effector CD8+ T (Teff) cells were significantly downregulated while naïve CD8+ T cells or Treg cells were obviously upregulated in P210-elevated CML patients after contracting COVID-19 compared to that in P210-unchanged or decreased CML patients. …”

Image 2_COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity.pdf by Na He (295300)

“…Our results showed that effector CD8+ T (Teff) cells were significantly downregulated while naïve CD8+ T cells or Treg cells were obviously upregulated in P210-elevated CML patients after contracting COVID-19 compared to that in P210-unchanged or decreased CML patients. …”